BioTech Medics 1st Year Anniversary Report
December 09 2005 - 9:00AM
PR Newswire (US)
DALLAS, Dec. 9 /PRNewswire-FirstCall/ -- Keith Houser, CEO of
BioTech Medics, Inc., (OTC Pink Sheets: BTMD) issued a statement
chronicling the accomplishments during the first year anniversary
of the reverse/merger between Corbel Holdings, Inc., and HaloLaser
BioTherapy, LLC. "During the past year BTMD has accomplished much,"
said Mr. Houser. "We closed on the reverse/merger on time. The
previous directors and officers were replaced immediately. Under
new management and a new board of directors we hired a CPA firm to
start an audit of the merged companies. The auditors have completed
IRS filings through 2004, but not completed the audit. We pledged
'no reverse stock split' and we have kept our word. "BioTech Medics
has acquired over $2.5 million in assets this year (with cash and
treasury stock) and has a steady revenue income in the management
agreement with Charles R. Crane MD & Associates in forming our
first Pain Management & Wellness Center in Dallas, Texas.
Additionally BTMD acquired 5 US Letters of Patent from FHJ and have
started marketing the proprietary SHBAN Cleaning & Disinfecting
Solution. BTMD entered into a distributorship agreement with Laser
Neurotherapy Development Labs and have sold the NeuroLase Medical
Laser device to clinics in the USA. We negotiated turnkey financing
for the laser acquisitions through First Financial Leasing &
Financing. Mr. Houser stated: "In 2004 Corbel had under $500,000 in
Real Estate Assets. Since the reverse/merger BTMD has had a 400%
increase in non-real estate Assets. BTMD estimates to close 2005
with combined Gross Revenues around $ 1 million. The 2005 BTMD
revenues are projected to be nearly 20 times higher than 2004.
"BTMD plans on closing on more new Pain Management & Wellness
Centers in 2006, as well as acquiring a permanent office building
in Dallas, Texas. We pledge to strive to add more assets and
increased revenue for the company to bring more value to the stock
and its more than 5,800 shareholders in 22 countries. This in turn
should provide BTMD the opportunity to become a reporting company
and the possibility to move up to a major exchange." For More
Information Contact BioTech Medics at 972-274-5533 or on the
Internet at: http://www.biotechmedics.com/ Safe Harbor for
Forward-Looking Statements This press contains forward-looking
statements within the meaning of The Private Securities Litigation
Reform Act of 1995 (the "Act"). In Particular, when used in the
preceding discussion, the words "plan," "expect," or "intend to,"
and similar conditional expressions are intended to identify
forward- looking statements within the meaning of the Act. Such
statements are subject to certain risks and uncertainties and
actual results could differ materially from those expressed. Such
risks and uncertainties include, but are not limited to, the
ability of the company to have adequate financing, market
conditions, the general acceptance of the Company's products and
technologies, competitive factors, timing, and other risks.
CONTACT: BioTech Medics, Inc., +1-972-274-5533 DATASOURCE: BioTech
Medics, Inc. CONTACT: BioTech Medics, Inc., +1-972-274-5533 Web
site: http://www.biotechmedics.com/
Copyright